Chemplast Sanmar

how big is Chemplast Sanmar?

As of Jun 06, Chemplast Sanmar Ltd has a market capitalization of 6,780.00 Cr, with recent net sales of 4,346.07 Cr and a net profit of -110.36 Cr over the last four quarters. Shareholder's funds are 1,700.58 Cr, and total assets are 6,030.30 Cr as of Mar'24.

Market Cap: As of Jun 06, Chemplast Sanmar Ltd has a market capitalization of 6,780.00 Cr, classifying it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters, which is consolidated data, amounts to 4,346.07 Cr. In contrast, the sum of Net Profit for the same period is -110.36 Cr.<BR><BR>Balance Sheet Snapshot: This is consolidated data for the latest annual period ending in Mar'24. The Shareholder's Funds are reported at 1,700.58 Cr, while Total Assets stand at 6,030.30 Cr.

What does Chemplast Sanmar do?

Chemplast Sanmar Ltd is a mid-cap company in the commodity chemicals industry, incorporated in 1985, with recent quarterly net sales of ₹1,151 Cr and a net loss of ₹54 Cr. It has a market cap of ₹6,735 Cr and key metrics include a debt-equity ratio of 0.54 and a return on equity of -5.34%.

Overview:<BR>Chemplast Sanmar Ltd operates in the commodity chemicals industry and is categorized as a mid-cap company.<BR><BR>History:<BR>Incorporated in 1985, Chemplast Sanmar Ltd was initially promoted as Urethanes India by Chemplast, the flagship of the Sanmar Group, Tamil Nadu. It became a fully-owned subsidiary of Chemplast in 1991, at which point it adopted its current name. The latest quarterly results reported net sales and net profit for March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 1,151 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: -54 Cr (Quarterly Results - Mar 2025)<BR>- Market cap: Rs 6,735 Cr (Mid Cap)<BR><BR>Key Metrics:<BR>- P/E: N/A (Loss Making)<BR>- Industry P/E: 47<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.54<BR>- Return on Equity: -5.34%<BR>- Price to Book: 3.27<BR><BR>Contact Details:<BR>Address: 9 Cathedral Road, Chennai Tamil Nadu: 600086 <BR>Tel: +91-44-28128500 <BR>Email: grd@sanmargroup.com <BR>Website: http://www.chemplastsanmar.com

Has Chemplast Sanmar declared dividend?

No Dividend History Available

Is Chemplast Sanmar overvalued or undervalued?

As of June 12, 2025, Chemplast Sanmar is considered overvalued with a PE ratio of -62.46 and an EV to EBITDA of 36.64, underperforming the Sensex with a stock return of -17.71% compared to the Sensex's 6.64%.

As of 12 June 2025, Chemplast Sanmar's valuation grade has moved from fair to expensive. The company is currently overvalued, with a PE ratio of -62.46, an EV to EBITDA ratio of 36.64, and a Price to Book Value of 3.33. These ratios indicate significant concerns regarding profitability and valuation relative to its assets.<BR><BR>In comparison to its peers, Chemplast Sanmar's valuation stands out unfavorably; for instance, Godrej Industries is rated attractive with a PE of 44.06 and an EV to EBITDA of 33.16. Additionally, Solar Industries is categorized as very expensive with a PE of 124.55 and an EV to EBITDA of 76.70. Furthermore, Chemplast Sanmar has underperformed the Sensex over the past year, with a stock return of -17.71% compared to the Sensex's 6.64%, reinforcing the notion that the stock is currently overvalued.

Who are the peers of the Chemplast Sanmar?

Chemplast Sanmar's peers include Tata Chemicals, India Glycols, GHCL, and others, with varying management risks and growth rates. Notably, India Glycols has the highest 1-year return at 99.07%, while Chemplast Sanmar has the lowest at -20.06%.

Peers: The peers of Chemplast Sanmar are Tata Chemicals, India Glycols, GHCL, Fischer Medical, Grauer & Weil, Tanfac Inds., Gujarat Alkalies, Blue Pearl Agri, Thirumalai Chem, and J.G.Chemicals.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL and Fischer Medical, while Good management risk is found at Chemplast Sanmar. Average management risk is seen at Tata Chemicals, India Glycols, Grauer & Weil, Tanfac Inds., Thirumalai Chem, and J.G.Chemicals, and the rest. Below Average management risk is present at Gujarat Alkalies, while Blue Pearl Agri does not qualify. Growth is Excellent at Tanfac Inds., while Below Average growth is noted at Chemplast Sanmar, Tata Chemicals, India Glycols, GHCL, Grauer & Weil, Gujarat Alkalies, Thirumalai Chem, and J.G.Chemicals, and the rest. Average growth is observed at Fischer Medical, while Excellent capital structure is seen at GHCL, Grauer & Weil, and Tanfac Inds. Average capital structure is found at Tata Chemicals and Thirumalai Chem, while Below Average capital structure is noted at Chemplast Sanmar, India Glycols, and Gujarat Alkalies, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is India Glycols at 99.07%, while Chemplast Sanmar has the lowest at -20.06%. This indicates that Chemplast Sanmar's return is significantly lower than that of India Glycols. Additionally, peers with a negative six-month return include Chemplast Sanmar, GHCL, Gujarat Alkalies, and Blue Pearl Agri.

Who are in the management team of Chemplast Sanmar?

As of March 2023, the management team of Chemplast Sanmar includes Vijay Sankar (Chairman), Ramkumar Shankar (Managing Director), and several independent and non-executive directors, totaling nine members. This team ensures effective governance and oversight of the company.

As of March 2023, the management team of Chemplast Sanmar includes the following individuals:<BR><BR>1. Vijay Sankar - Chairman (Non-Executive)<BR>2. Ramkumar Shankar - Managing Director<BR>3. Chandran Ratnaswami - Non-Executive & Non-Independent Director<BR>4. Lakshmi Vijayakumar - Independent Director<BR>5. Aditya Jain - Independent Director<BR>6. Sanjay Bhandarkar - Independent Director<BR>7. Prasad R Menon - Independent Director<BR>8. M Raman - Company Secretary & Compliance Officer<BR>9. Vikram Taranath Hosangady - Non-Executive Director<BR><BR>This diverse team comprises both executive and non-executive members, with various independent directors contributing to the governance of the company.

Who are the top shareholders of the Chemplast Sanmar?

The top shareholders of Chemplast Sanmar are Sanmar Holdings Limited with 54.99%, mutual funds owning 24.11%, and foreign institutional investors holding 13.27%. SBI Long Term Equity Fund is the largest public shareholder at 9.82%, while individual investors hold about 4.57%.

The top shareholders of Chemplast Sanmar include Sanmar Holdings Limited, which holds the largest stake at 54.99%. Other significant shareholders are mutual funds, which collectively own 24.11% through 12 schemes, and foreign institutional investors (FIIs) with a combined holding of 13.27% across 80 FIIs. Additionally, SBI Long Term Equity Fund is the highest public shareholder with 9.82%. Individual investors hold about 4.57% of the company.

How has been the historical performance of Chemplast Sanmar?

Chemplast Sanmar's historical performance shows a decline in net sales and profits from a peak in March 2022, with net sales dropping from 5,891.99 Cr to 4,346.07 Cr by March 2025, and profit after tax turning negative at -110.36 Cr. Despite an increase in total assets and liabilities, the company has faced significant challenges in profitability and cash flow in recent years.

Answer:<BR>The historical performance of Chemplast Sanmar shows a fluctuating trend in key financial metrics over the years.<BR><BR>Breakdown:<BR>Chemplast Sanmar's net sales peaked at 5,891.99 Cr in March 2022 but have since declined to 4,346.07 Cr in March 2025. The total operating income followed a similar pattern, reaching a high of 5,891.99 Cr in March 2022 before dropping to 4,346.07 Cr in March 2025. The company experienced significant variations in operating profit, with a high of 1,254.29 Cr in March 2022, but a decline to 265.72 Cr by March 2025. Profit before tax turned negative in March 2024 and 2025, with figures of -225.57 Cr and -169.07 Cr, respectively, after being positive in earlier years. The profit after tax also reflected this downturn, moving from a high of 648.65 Cr in March 2022 to -110.36 Cr in March 2025. Total liabilities increased from 4,107.54 Cr in March 2020 to 6,503.19 Cr in March 2025, while total assets rose from 4,107.54 Cr to 6,503.19 Cr in the same period. Cash flow from operating activities has been negative in the last two years, with -244.00 Cr in March 2024 and a further decline in March 2025. Overall, Chemplast Sanmar's financial performance indicates challenges in profitability and cash flow, despite growth in total assets and liabilities.

Is Chemplast Sanmar technically bullish or bearish?

As of December 2, 2025, Chemplast Sanmar's technical trend has shifted to a bearish stance with moderate strength, supported by bearish indicators across multiple timeframes, despite some mildly bullish signals in the monthly analysis.

As of 2 December 2025, the technical trend for Chemplast Sanmar has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this assessment include a bearish MACD on the weekly timeframe, bearish signals from Bollinger Bands and KST on both weekly and monthly timeframes, and bearish moving averages on the daily chart. The Dow Theory also confirms a bearish trend across both weekly and monthly perspectives. Despite a mildly bullish monthly MACD and bullish monthly RSI, the overall technical picture remains negative, particularly in the short term.

When is the next results date for Chemplast Sanmar Ltd?

The next results date for Chemplast Sanmar Ltd is 07 February 2026.

The next results date for Chemplast Sanmar Ltd is scheduled for 07 February 2026.

Are Chemplast Sanmar Ltd latest results good or bad?

Chemplast Sanmar Ltd's latest results are unfavorable, showing a net loss of ₹51.04 crores in Q3 FY26, a 63.28% decline year-on-year, despite a slight revenue increase. The company faces significant financial challenges, including high debt and operational inefficiencies.

Chemplast Sanmar Ltd's latest results indicate a challenging financial situation. In Q3 FY26, the company reported a net loss of ₹51.04 crores, which is a significant decline of 63.28% year-on-year and a worsening of 20.56% quarter-on-quarter. While revenue saw a modest increase of 4.07% year-on-year to ₹1,033.20 crores, it experienced a concerning sequential decline of 6.06% from the previous quarter.<BR><BR>The operating margin improved slightly to 4.19%, up from 2.60% a year earlier, but this remains well below industry standards. The company's persistent operational inefficiencies and high fixed costs, particularly its interest expenses of ₹60.33 crores, have overshadowed these improvements. The interest costs alone exceeded the operating profit, leading to a pre-tax loss of ₹62.19 crores.<BR><BR>Overall, the results reflect a company grappling with significant financial challenges, including a high debt burden and negative profitability metrics. The outlook appears bleak, with ongoing losses and limited pricing power in a competitive market. Therefore, the latest results can be characterized as unfavorable.

Should I buy, sell or hold Chemplast Sanmar Ltd?

Which are the latest news on Chemplast Sanmar?

Why is Chemplast Sanmar Ltd falling/rising?

As of 23-Mar, Chemplast Sanmar Ltd's stock is declining to Rs 257.65, down 8.1%, due to poor financial performance, high debt levels, and underperformance against market benchmarks. The stock has also experienced significant selling pressure and a trend reversal after previous gains.

As of 23-Mar, Chemplast Sanmar Ltd's stock price is falling, currently at Rs 257.65, reflecting a change of -22.7 (-8.1%). This decline can be attributed to several factors highlighted in the source data. <BR><BR>Firstly, the stock has underperformed its sector, with a performance today that is -4.36% lower than the sector average. Additionally, the stock has experienced a trend reversal, having fallen after three consecutive days of gains. The intraday low of Rs 255.9 indicates significant selling pressure, with the stock dropping by as much as -8.72% during the day.<BR><BR>Moreover, the company's financial health raises concerns. It has a high Debt to EBITDA ratio of 4.30 times, indicating a low ability to service its debt. This is compounded by poor long-term growth, as net sales have declined at an annual rate of -6.66% and operating profit has plummeted by -164.18% over the last five years. The recent financial results also reflect a troubling trend, with net sales falling by -23.1% compared to the previous four-quarter average and a significant drop in profit before tax and profit after tax.<BR><BR>The stock has consistently underperformed against benchmarks, generating a return of -43.40% over the past year, which is starkly contrasted by the benchmark's performance. This consistent underperformance, coupled with negative operating profits and a lack of profitability per unit of shareholders' funds, contributes to the stock's decline.<BR><BR>In summary, Chemplast Sanmar Ltd's stock is falling due to a combination of poor financial performance, high debt levels, and a lack of growth, alongside underperformance against market benchmarks.

Why is Chemplast Sanmar Ltd falling/rising?

As of 24-Mar, Chemplast Sanmar Ltd's stock price is rising to 260.20, reflecting a 0.79% increase. However, this short-term gain contrasts with long-term challenges, including a 45.71% decline over the past year and concerns about financial health due to high debt and negative operating profits.

As of 24-Mar, Chemplast Sanmar Ltd's stock price is rising, currently at 260.20, reflecting a change of 2.05 (0.79%) upward. This increase can be attributed to several factors. Firstly, the stock opened with a significant gain of 4.49% today and reached an intraday high of Rs 269.75. Additionally, there has been a notable rise in investor participation, with delivery volume increasing by 140.45% compared to the 5-day average, indicating heightened interest among investors.<BR><BR>Despite the positive movement today, it is important to note that the stock has underperformed its sector by 1.6% and has shown a decline of 1.18% over the past month. Furthermore, the stock has experienced a substantial drop of 45.71% over the past year, which is significantly worse than the broader market's decline of 5.02%. <BR><BR>The company's financial health presents a mixed picture. While it boasts a high management efficiency with a Return on Capital Employed (ROCE) of 16.72% and substantial institutional holdings at 38.68%, it also faces challenges such as a high Debt to EBITDA ratio of 4.30 times, indicating a low ability to service its debt. Moreover, the company has reported negative operating profits and declining net sales over the past five years, which raises concerns about its long-term growth prospects.<BR><BR>In summary, while Chemplast Sanmar Ltd is experiencing a rise in its stock price today, this is juxtaposed against a backdrop of significant long-term challenges and underperformance relative to both the market and its sector.

Why is Chemplast Sanmar Ltd falling/rising?

As of 25-Mar, Chemplast Sanmar Ltd's stock is rising to 271.90, up 4.76%, driven by short-term gains and outperforming its sector today. However, the stock has declined 40.78% over the past year and faces long-term challenges, including high debt and decreasing sales.

As of 25-Mar, Chemplast Sanmar Ltd's stock price is rising, currently at 271.90, reflecting an increase of 12.35 (4.76%). This upward movement can be attributed to several factors. Firstly, the stock has outperformed its sector by 3.06% today and has shown a consecutive gain over the last two days, accumulating a total return of 5.33% during this period. Additionally, the stock opened with a gain of 2.1% today and reached an intraday high of Rs 280.75, which is an increase of 8.17%.<BR><BR>Despite these positive short-term movements, it is important to note that the stock has faced significant challenges in the longer term. Over the past year, Chemplast Sanmar Ltd has experienced a decline of 40.78%, and its performance over the last three years has consistently underperformed against benchmarks. The company has a high Debt to EBITDA ratio of 4.30 times, indicating a low ability to service its debt, and its net sales have decreased at an annual rate of -6.66% over the last five years. <BR><BR>While the stock is currently rising, these underlying issues suggest a complex situation where short-term gains may not reflect the company's long-term viability.